Exicure (XCUR) Change in Receivables (2020 - 2026)
Exicure (XCUR) reported Change in Receivables of $2000.0 for Q1 2026, up 100.15% on a YoY basis from $999.25 in Q1 2025, and down 98.26% quarter-over-quarter from $115000.0 in Q4 2025.
Exicure (XCUR) Change in Receivables (2020 - 2026) Analysis & Trends
Exicure has reported Change in Receivables for 5 years, with the latest figure at $2000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 100.15% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2026 stood at -$1000.0 (up 99.88% YoY), and the FY2025 full-year result was -$1.3 million, down 365.22% from the prior year.
- Change in Receivables for Q1 2026 stood at $2000.0, down from $115000.0 in the prior quarter.
- The five-year high for Change in Receivables was $791000.0 in Q3 2024, with the low at -$1.3 million in Q1 2025.
- Historically, Change in Receivables has averaged -$104250.0 across 3 years, with a median of -$10500.0 in 2025.
- The largest YoY upside for Change in Receivables was 113.87% in 2025 against a maximum downside of 117.46% in 2025.
- Exicure's Change in Receivables stood at -$829000.0 in 2024, then soared by 113.87% to $115000.0 in 2025, then tumbled by 98.26% to $2000.0 in 2026.
- The last three Change in Receivables figures came in at $2000.0 (Q1 2026), $115000.0 (Q4 2025), and -$23000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 115,000.00 |
| Dec 31, 2025 | 115,000.00 |
| Sep 30, 2025 | -23,000.00 |
| Sep 30, 2025 | -23,000.00 |
| Jun 30, 2025 | -95,000.00 |
| Jun 30, 2025 | -95,000.00 |
| Mar 31, 2025 | -1.34 Mn |
| Mar 31, 2025 | -1.34 Mn |
| Dec 31, 2024 | -829,000.00 |
| Dec 31, 2024 | -829,000.00 |
| Sep 30, 2024 | 791,000.00 |
| Sep 30, 2024 | 791,000.00 |
| Jun 30, 2024 | 544,000.00 |
| Jun 30, 2024 | 544,000.00 |
| Mar 31, 2021 | -11,000.00 |
| Mar 31, 2021 | -11,000.00 |
| Dec 31, 2020 | -34,000.00 |
| Dec 31, 2020 | -34,000.00 |